https://www.selleckchem.com/pr....oducts/pirfenidone.h
Two women terminated unplanned pregnancies. Miscarriage rates were consistent with that known in the general U.S. Five of the six women who discontinued ETI out of concern for unknown fetal risk restarted because of clinical deterioration. No infant cataracts were reported though only two infants were formally evaluated. In the context of the known increased rate of complications in women with CF and their infants, data from this retrospective survey is reassuring for women who choose to continue ETI during pregnancy. However, a lar
Like
Comment
Share
